Eterna Therapeutics Inc./$ERNA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
Ticker
$ERNA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
6
ISIN
US1140822099
Website
ERNA Metrics
BasicAdvanced
$14M
-
-$1.80
7.35
-
Price and volume
Market cap
$14M
Beta
7.35
52-week high
$0.30
52-week low
$0.15
Average daily volume
204K
Financial strength
Current ratio
0.212
Quick ratio
0.199
Long term debt to equity
-7.042
Total debt to equity
-48.437
Interest coverage (TTM)
-2.38%
Management effectiveness
Return on assets (TTM)
-32.42%
Return on equity (TTM)
984.70%
Valuation
Price to revenue (TTM)
10.973
Price to book
-2.01
Price to tangible book (TTM)
-1.5
Price to free cash flow (TTM)
-0.407
Growth
Revenue change (TTM)
365.22%
Earnings per share change (TTM)
-57.73%
3-year earnings per share growth (CAGR)
-65.96%
ERNA News
AllArticlesVideos
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
GlobeNewsWire·2 days ago
Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations
GlobeNewsWire·2 weeks ago
Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Eterna Therapeutics Inc. stock?
Eterna Therapeutics Inc. (ERNA) has a market cap of $14M as of May 30, 2025.
What is the P/E ratio for Eterna Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Eterna Therapeutics Inc. (ERNA) stock is 0 as of May 30, 2025.
Does Eterna Therapeutics Inc. stock pay dividends?
No, Eterna Therapeutics Inc. (ERNA) stock does not pay dividends to its shareholders as of May 30, 2025.
When is the next Eterna Therapeutics Inc. dividend payment date?
Eterna Therapeutics Inc. (ERNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Eterna Therapeutics Inc.?
Eterna Therapeutics Inc. (ERNA) has a beta rating of 7.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.